Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -21.323% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
[a] CSC1=NNC(c2ccc(C(C)(C)C)cc2)=NN1
[b] CCCCCCCn1c(=O)c(C(=O)OC)c(N)c2ccccc21
[c] Cc1cccc2cc3c(N)c(C(=O)N4CCCc5ccccc54)sc3nc12
[d] CN(C)c1nc(Oc2ccc(C(=O)OCC(=O)Nc3ccccc3)cc2)nc(N(C)C)n1
Answer: a. CSC1=NNC(c2ccc(C(C)(C)C)cc2)=NN1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CSC1=NNC(c2ccc(C(C)(C)C)cc2)=NN1
CSC1=NNC(c2ccc(C(C)(C)C)cc2)=NN1
3-(4-tert-butylphenyl)-6-methylsulfanyl-1,4-dihydro-1,2,4,5-tetrazine